Temasek Holdings Private Ltd Lowers Position in GE HealthCare Technologies Inc. $GEHC

Temasek Holdings Private Ltd cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,318,290 shares of the company’s stock after selling 12,225 shares during the period. Temasek Holdings Private Ltd owned about 0.29% of GE HealthCare Technologies worth $108,126,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Laurel Wealth Advisors LLC bought a new stake in GE HealthCare Technologies during the fourth quarter valued at about $26,000. Optima Capital LLC bought a new stake in GE HealthCare Technologies during the fourth quarter valued at about $27,000. Godfrey Financial Associates Inc. bought a new stake in GE HealthCare Technologies during the fourth quarter valued at about $27,000. Montag A & Associates Inc. raised its holdings in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC raised its holdings in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares during the period. 82.06% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have commented on GEHC shares. Stifel Nicolaus set a $80.00 price target on GE HealthCare Technologies in a report on Wednesday, April 29th. JPMorgan Chase & Co. reduced their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Weiss Ratings cut GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th. BNP Paribas Exane reduced their target price on GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. Finally, UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and reduced their target price for the stock from $75.00 to $69.00 in a report on Thursday, May 21st. Nine analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $80.21.

Insider Buying and Selling

In related news, Director Kevin Lobo purchased 10,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was bought at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director owned 14,363 shares in the company, valued at approximately $921,817.34. The trade was a 229.20% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Frank R. Jimenez purchased 1,750 shares of the company’s stock in a transaction that occurred on Thursday, April 30th. The stock was bought at an average price of $60.45 per share, with a total value of $105,787.50. Following the transaction, the insider owned 93,932 shares of the company’s stock, valued at $5,678,189.40. This represents a 1.90% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought a total of 21,847 shares of company stock valued at $1,361,355 in the last quarter. 0.36% of the stock is currently owned by insiders.

GE HealthCare Technologies Trading Down 0.6%

Shares of GEHC stock opened at $64.76 on Tuesday. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The stock’s 50-day moving average price is $66.21 and its 200-day moving average price is $75.07. The stock has a market capitalization of $29.46 billion, a price-to-earnings ratio of 15.49, a price-to-earnings-growth ratio of 1.47 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.